Clinicopathological Characteristics and Mutation Profiling in Primary Cutaneous Melanoma

被引:28
|
作者
Yaman, Banu [1 ]
Akalin, Taner [1 ]
Kandiloglu, Gulsen [1 ]
机构
[1] Ege Univ, Fac Med, Dept Pathol, TR-35100 Izmir, Turkey
关键词
melanoma subtypes; mutation profiling; BRAF V600E; V600K; NRAS; KIT; KRAS; sun exposure; N-RAS MUTATIONS; BRAF MUTATIONS; NRAS MUTATIONS; PATHOLOGICAL FEATURES; MELANOCYTIC LESIONS; MALIGNANT-MELANOMA; SOMATIC MUTATIONS; COPY NUMBER; KIT; ACTIVATION;
D O I
10.1097/DAD.0000000000000241
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The incidence of mutations in malignant melanoma varies remarkably according to the subtype of melanoma, and this in itself is affected by racial and geographical factors. Studies screening melanoma case series for different types of mutations are relatively rare. Method: The authors analyzed the frequency of various somatic point mutations of 10 genes in 106 primary cutaneous melanoma cases. The mutations (BRAF, NRAS, KIT, CDKN2A, KRAS, HRAS, PIK3CA, STK11, GNAQ, CTNNB1) were evaluated with real-time PCR-based PCR-Array through allele-specific amplification, and the results were correlated with various clinicopathological characteristics. Results: Mutations were found in 64.2% of the melanomas overall. BRAF (42.5%), NRAS (15.1%), and CDKN2A (13.2%) were the 3 most common mutations. BRAF and NRAS mutations were more frequent in nodular and superficial spreading melanomas (P < 0.001). Associations with BRAF mutation were as follows: male gender [odds ratio (OR) = 2.4], younger age (OR = 2.7), superficial spreading (OR = 15.6) and nodular melanoma (OR = 9.5), trunk localization (OR = 6.3), and intermittent sun exposure (OR = 4.6). A considerable percentage of V600K (44.4%) mutations were found among the BRAF mutations, whereas KIT mutations (3.8%) were less frequent. Multiple mutations were detected in 13.2% of the melanomas. The most common co-occurrences were in the BRAF, NRAS, and CDKN2A genes. Conclusions: The authors analyzed 10 somatic mutations in the main subtypes of primary cutaneous melanomas from the western region of Turkey. Mutations were found in 64.2% of the melanomas overall. The most common mutations were in the BRAF and NRAS genes. In addition to other less common mutations, a notable number of multiple mutations were encountered. The multiplicity and concurrence of mutations in this study may provide further study areas for personalized targeted therapy.
引用
收藏
页码:389 / 397
页数:9
相关论文
共 50 条
  • [1] Clinicopathological features and NRAS gene mutation status in patients with primary cutaneous melanoma
    Aksenenko, M.
    Ruksha, T.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S247 - S247
  • [2] Clinicopathological characteristics and survival of primary malignant melanoma of the esophagus
    Hashimoto, Tadayoshi
    Makino, Tomoki
    Yamasaki, Makoto
    Tanaka, Koji
    Miyazaki, Yasuhiro
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Motoori, Masaaki
    Kimura, Yutaka
    Nakajima, Kiyokazu
    Morii, Eiichi
    Mori, Masaki
    Doki, Yuichiro
    [J]. ONCOLOGY LETTERS, 2019, 18 (02) : 1872 - 1880
  • [3] Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma
    Kangas-Dick, Aaron W.
    Greenbaum, Alissa
    Gall, Victor
    Groisberg, Roman
    Mehnert, Janice
    Chen, Chunxia
    Moore, Dirk F.
    Berger, Adam C.
    Koshenkov, Vadim
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4582 - 4589
  • [4] Validation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma
    Kangas-Dick, A. W.
    Greenbaum, A.
    Gall, V. A.
    Groisberg, R.
    Mehnert, J.
    Koshenkov, V.
    Berger, A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S175 - S175
  • [5] Gene expression profiling of primary cutaneous melanoma and clinical outcome
    Winnepenninckx, VR
    Lazar, V
    Michiels, S
    Dessen, P
    Stas, M
    Alonso, SR
    Avril, MF
    Romero, PLO
    Robert, T
    Balacescu, O
    Eggermont, AMM
    Lenoir, G
    Sarasin, A
    Tursz, T
    van den Oord, JJ
    Spatz, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (07) : 472 - 482
  • [6] Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma
    Aaron W. Kangas-Dick
    Alissa Greenbaum
    Victor Gall
    Roman Groisberg
    Janice Mehnert
    Chunxia Chen
    Dirk F. Moore
    Adam C. Berger
    Vadim Koshenkov
    [J]. Annals of Surgical Oncology, 2021, 28 : 4582 - 4589
  • [7] Molecular profiling of melanoma brain metastases (MBM) compared to primary cutaneous melanoma (CM).
    In, Gino Kim
    Poorman, Kelsey Anne
    Saul, Michelle
    O'Day, Steven
    Farma, Jeffrey M.
    Daveluy, Steven
    Olszanski, Anthony J.
    Gordon, Michael S.
    Thomas, Jacob Stephen
    Eisenberg, Burton Larry
    Flaherty, Lawrence E.
    Gibney, Geoffrey Thomas
    Atkins, Michael B.
    Vanderwalde, Ari M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] The frequency and clinicopathological significance of NRAS mutations in primary cutaneous nodular melanoma in Indonesia
    Rinonce, Hanggoro Tri
    Sastri, Deflen Jumatul
    Trisnawati, Fita
    Kameswari, Bidari
    Ferronika, Paranita
    Irianiwati
    [J]. CANCER REPORTS, 2022, 5 (01)
  • [9] CUTANEOUS MELANOMA OF THE EYELID - CLINICOPATHOLOGICAL FEATURES
    GROSSNIKLAUS, HE
    MCLEAN, IW
    [J]. OPHTHALMOLOGY, 1991, 98 (12) : 1867 - 1873
  • [10] Clinicopathological characteristics and mutation profile of BRAF and NRAS mutation in cutaneous melanomas in the Western Turkish population
    Evrenos, Mustafa Kursat
    Temiz, Peyker
    Cam, Fethi Sirri
    Yaman, Murat
    Yoleri, Levent
    Ermertcan, Aylin Turel
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (05) : 973 - 979